Journal of the Korean Society of Laryngology, Phoniatrics and Logopedics (대한후두음성언어의학회지)

The Korean Society of Laryngology, Phoniatrics and Logopedics. (대한후두음성언어의학회)
권호 표지

The Management of Systemic Voice Disorders

전신질환과 관련된 음성장애의 치료

  • Woo, Joo Hyun (Department of Otolaryngology-Head & Neck Surgery, Gachon University, School of Medicine, Gil Medical Center)
  • 우주현 (가천대학교 의과대학 길병원 이비인후-두경부외과학교실)
  • Received : 2016.05.18
  • Accepted : 2016.05.23
  • Published : 2016.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Variable systemic diseases affect larynx and vocal fold and result in voice change. Asthma and chronic obstructive pulmonary disease make increase of intra-abdomimal pressure followed by reflux of gastric acid, which stimulate vagal-bronchopulomary reflex aggravating cough and respiratory disturbance. Fungal laryngitis in the general population is extremely rare, but can occur in immunocompromised AIDS patients. Although, initially, empirical antifungal therapy for candidiasis is often given without biopsy, diagnostic direct laryngoscopy and biopsy is imperative if a substantial clinical response is not rapidly achieved. In the highly active anti-retroviral therapy era, HIV-positive patients are living longer and are at higher risk for developing non-AIDS-defining malignancies. The incidence of head and neck cancer (HNC) which is related with human papilloma virus infection has increased. The survival is significantly lower among the AIDS-HNC patients with CD4 counts ${\leq}200cells/{\mu}L$. Rheumatoid arthritis (RA) cause voice disturbance by developing cricoarytenoid joints fixation or nodule on vocal fold. Post-menopausal voice disorder (PMVD) is caused by decreased secretion of estrogen-progesterone resulting in decrease of fundamental frequency (F0). Hormonal replacement therapy is helpful to reduce F0 decrease. RA and PMVD result in slight voice change, but it could crucial in professional voice user.

Keywords

References

  1. Mohammadzadeh A, Heydari E, Azizi F. Speech impairment in primary hypothyroidism. J Endocrinol Invest 2011;34:431-3.
  2. Bachelot A, Touraine P. Health status of adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Presse Med 2014;43:428-37.
  3. Moore C, Shalet S, Manickam K, Willard T, Maheshwari H, Baumann G. Voice abnormality in adults with congenital and adult-acquired growth hormone deficiency. J Clin Endocrinol Metab 2005; 90:4128-32.
  4. Krouse JH. Allergy and laryngeal disorders. Curr Opin Otolaryngol Head Neck Surg 2016;24:221-5.
  5. Tami TA, Ferlito A, Rinaldo A, Lee KC, Singh B. Laryngeal pathology in the acquired immunodeficiency syndrome: diagnostic and therapeutic dilemmas. Ann Otol Rhinol Laryngol 1999;108:214-20.
  6. Speyer R, Speyer I, Heijnen MA. Prevalence and relative risk of dysphonia in rheumatoid arthritis. J Voice 2008;22:232-7.
  7. Hoit JD, Jenks CL, Watson PJ, Cleveland TF. Respiratory function during speaking and singing in professional country singers. J Voice 1996;10:39-49.
  8. Shiba TL, Chhetri DK. Dynamics of phonatory posturing at phonation onset. The Laryngoscope 2015 Dec 21. doi: 10.1002/lary.25816. [Epub ahead of print]
  9. Yumoto E. Aerodynamics, voice quality, and laryngeal image analysis of normal and pathologic voices. Curr Opin Otolaryngol Head Neck Surg 2004;12:166-73.
  10. Blasi F, Bettoncelli G, Canonica GW, Centanni S, Crimi N, Di Maria G, et al. The management of asthma in the phenotype and biomarker era: The proposal of a new diagnostic-therapeutic model 2016 Apr 6:0. [Epub ahead of print]
  11. Brisk R, Heaney LG. Asthma control and exacerbations: two different sides of the same coin. Curr Opin Pulm Med 2016;22:32-7.
  12. Guirguis-Blake JM, Senger CA, Webber EM, Mularski RA, Whitlock EP. Screening for Chronic Obstructive Pulmonary Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force. Jama 2016;315:1378-93.
  13. Mantoani LC, Rubio N, McKinstry B, MacNee W, Rabinovich RA. Interventions to modify physical activity in patients with COPD: a systematic review. Eur Respir J. 2016 Apr 21. pii: ERJ-01744-2015. doi: 10.1183/13993003.01744-2015. [Epub ahead of print]
  14. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index(RSI). J Voice 2002;16:274-77.
  15. Hamdan AL, Jaffal H, Btaiche R, Turfe ZA, Bawab I, Kanj N, et al. Laryngopharyngeal symptoms in patients with asthma: a crosssectional controlled study. Clinical Respir J 2016;10:40-7.
  16. Hamdan AL, Ziade G, Turfe Z, Beydoun N, Sarieddine D, Kanj N. Laryngopharyngeal symptoms in patients with chronic obstructive pulmonary disease. Eur Arch Otorhinolaryngol 2016;273:953-8.
  17. Jung YH, Lee DY, Kim DW, Park SS, Heo EY, Chung HS, et al. Clinical significance of laryngopharyngeal reflux in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2015;10:1343-51.
  18. Amarasiri DL, Pathmeswaran A, Dassanayake AS, De Silva AP, Ranasinha CD, de Silva HJ. Esophageal motility, vagal function and gastroesophageal reflux in a cohort of adult asthmatics. BMC Gastroenterol 2012;12:140-7.
  19. Ayazi S, DeMeester SR, Hsieh CC, Zehetner J, Sharm G, Grant KS, et al. Thoraco-abdominal pressure gradients during the phases of respiration contribute to gastroesophageal reflux disease. Dig Dis Sci 2011;56:1718-22.
  20. Levy ML, Dekhuijzen PN, Barnes PJ, Broeders M, Corrigan CJ, Chawes BL, et al. Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT). NPJ Prim Care Respir Med 2016;26:16017-23.
  21. Lavy JA, Wood G, Rubin JS, Harries M. Dysphonia associated with inhaled steroids. J Voice 2000;14:581-8.
  22. Gallivan GJ, Gallivan KH, Gallivan HK. Inhaled corticosteroids: hazardous effects on voice-an update J Voice 2007;21:101-11.
  23. DelGaudio JM. Steroid inhaler laryngitis: dysphonia caused by inhaled fluticasone therapy. Arch Otolaryngol Head Neck Surg 2002; 128:677-81.
  24. Bhalla RK, Watson G, Taylor W, Jones AS, Roland NJ. Acoustic analysis in asthmatics and the influence of inhaled corticosteroid therapy. J Voice 2009;23:505-11.
  25. Moss JA. HIV/AIDS Review. Radiol Technol 2013;84:247-67.
  26. Kim YJ, Woo JH, Kim MJ, Park DW, Song JY, Kim SW, et al. Opportunistic diseases among HIV-infected patients: a multicenternationwide Korean HIV/AIDS cohort study, 2006 to 2013. Korean J Intern Med. 2016 Apr 27. doi: 10.3904/kjim.2014.322. [Epub ahead of print]
  27. Klein AM, Tiu C, Lafreniere D. Malignant mimickers: chronic bacterial and fungal infections of the larynx. J Voice 2005;19:151-7.
  28. Mochloulis G, Irving RM, Grant HR, Miller RF. Laryngeal Kaposi's sarcoma in patients with AIDS. Journal Laryngol Otol 1996;110:1034-7.
  29. D’Souza G, Carey TE, William WN Jr, Nguyen ML, Ko EC, Riddell J 4th, et al. Epidemiology of head and neck squamous cell cancer among HIV-infected patients. J Acquir Immune Defic Syndr 2014; 65:603-10.
  30. Grew DJ, Cooper BT, Nguy S, Halperin J, Sanfilippo NJ. Toxicity and disease-related outcomes after radiotherapy for head and neck cancer in human immunodeficiency virus-positive patients. Front Oncol 2014;4:316-21.
  31. Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016 May 3. pii: S0140-6736(16)30173-8. doi: 10.1016/S0140-6736(16)30173-8. [Epub ahead of print] Review.
  32. Abe K, Mitsuka T, Yamaoka A, Yamashita K, Yamashita M, Norimoto M, et al. Sudden glottic stenosis caused by cricoarytenoid joint involvement due to rheumatoid arthritis. Intern Med 2013;52:2469-72.
  33. Berjawi G, Uthman I, Mahfoud L, Husseini ST, Nassar J, Kotobi A et al. Cricothyroid joint abnormalities in patients with rheumatoid arthritis. J Voice 2010;24:732-7.
  34. Greco A, Fusconi M, Macri GF, Marineli C, Poletini E, Benincasa AT, et al. Cricoarytenoid joint involvement in rheumatoid arthritis: radiologic evaluation. Am J Otolaryngol 2012;33:753-5.
  35. Hilgert E, Toleti B, Kruger K, Nejedlo I. Hoarseness due to bamboo nodes in patients with autoimmune diseases: a review of literature. J Voice 2008;22:343-50.
  36. Li L, Saigusa H, Nakazawa Y, Nakamura T, Komachi T, Yamaguchi S, et al. A pathological study of bamboo nodule of the vocal fold. J Voice 2010;24:738-41.
  37. Murano E, Hosako-Naito Y, Tayama N, Oka T, Miyaji M, Kumada M, et al. Bamboo node: primary vocal fold lesion as evidence of autoimmune disease. J Voice 2001;15:441-50.
  38. Prelevic GM, Kocjan T, Markou A. Hormone replacement therapy in postmenopausal women. Minerva Endocrinol 2005;30:27-36.
  39. Abitbol J, Abitbol P, Abitbol B. Sex hormones and the female voice. J Voice 1999;13:424-46.
  40. Brunings JW, Schepens JJ, Peutz-Kootstra CJ, Kross KW. The expression of estrogen and progesterone receptors in the human larynx. J Voice 2013;27:376-80.
  41. Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, et al. Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 2010;95:5110-21.
  42. Raj A, Gupta B, Chowdhury A, Chadha S. A study of voice changes in various phases of menstrual cycle and in postmenopausal women. J Voice 2010;24:363-8.
  43. Boulet MJ, Oddens BJ. Female voice changes around and after the menopause--an initial investigation. Maturitas 1996;23:15-21.
  44. D'Haeseleer E, Depypere H, Claeys S, Baudonck N, Van Lierde K. The impact of hormone therapy on vocal quality in postmenopausal women. J Voice 2012;26:671.e1-7.
  45. D’Haeseleer E, Depypere H, Claeys S, Van Borsel J, Van Lierde K. The menopause and the female larynx, clinical aspects and therapeutic options: a literature review. Maturitas 2009;64:27-32.